Sales and Marketing

Showing 15 posts of 11528 posts found.

Pfizer’s biosimilar gets a second knock-back from FDA

June 23, 2017 Medical Communications, Sales and Marketing Amgen, Epogen, FDA, Pfizer

Pfizer has been dealt a stinging blow by the FDA, after it received a second complete response letter from the …
novartis_outside_1

Novartis lung cancer combo receives FDA approval

June 23, 2017 Medical Communications, Sales and Marketing NSCLC, Novartis

Novartis has revealed that its drug Tafinlar (dabrafenib) has received approval from the FDA for use in combination with Mekinist …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 23, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

We’re officially into summer, and the weekend is here. This week saw a number of stories that piqued the attention …
novartis_headquarters

Novartis pulls off surprise success in cardiovascular risk

June 22, 2017 Research and Development, Sales and Marketing Novartis

Novartis has posted positive news from the Cantos clinical trial study that saw its drug, Canakinumab, pull of a surprise …

FDA’s Gottlieb draws those ‘gaming’ system into pricing debate

June 22, 2017 Medical Communications, Sales and Marketing Drug pricing, FDA, Trump

President Trump spoke often of how pharmaceutical companies were ‘getting away with murder’, in regards to drug pricing, and now …
shire_image

10 years later, Shire gains FDA approval for ADHD drug

June 21, 2017 Research and Development, Sales and Marketing ADHD, Shire

Shire has revealed that the FDA has approved its long-acting and interestingly named ADHD drug, Mydayis. The approval comes more …

Thermo Fisher Scientific announces single quadrupole mass spectrometer and specialised columns

June 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

Thermo Fisher Scientific Inc., the world leader in serving science, today announced new technologies that are designed to allow analytical …
shutterstock_232245868

Severe asthma patients require more support, Novartis study suggests

June 19, 2017 Research and Development, Sales and Marketing Novartis, asthma

A new study from Novartis has indicated that patients suffering from severe asthma still do not get adequate support to …
shutterstock_95714119

Sudanese research centre launches first-ever mycetoma trial

June 19, 2017 Research and Development, Sales and Marketing mycetoma

A significant step forward has been made in moving towards a treatment for neglected tropical disease mycetoma as the first-ever …

Making strides in hepatitis

June 19, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Janssen, Johnson & Johnson

Pharmafocus caughtup with Lawrence Blatt, Janssen’s Global Therapeutic Area Head, Infectious Diseases and Vaccines, to discuss the progress being made in the …
mosquito

Pulses of light may offer ward against mosquitos

June 19, 2017 Research and Development, Sales and Marketing malaria, mosquito

Research emerging from scientists at the University of Notre Dame has found that exposing mosquitos to light during the night …
shutterstock

First-of-its-kind blood test unlocks precision treatment options for prostate cancer

June 19, 2017 Research and Development, Sales and Marketing

AstraZeneca’s Lynparza (olparib) is making yet another impact following its impressive showing this month in the ovarian cancer space, with …
novartis_window

Novartis receives European biosimilar approval for Roche blockbuster

June 19, 2017 Sales and Marketing Novartis, Rituxan, Rixathon, Roche

Sandoz, a division within Novartis, has received European Commission approval for its biosimilar version of Roche’s Rituxan (also known as …
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

June 16, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing top ten

The weather is heating up as we head into summer, and another week is behind us, meaning another run-down of …
bicycle_therapeutics

Cambridge start-up secures £40 million to trial innovative cancer drugs

June 16, 2017 Medical Communications, Research and Development, Sales and Marketing Bicycle Therapeutics, Cambridge, Cancer

Bicycle Therapeutics, a biotech start-up based in Cambridge, UK, has just raised £40 million from a range of investors including …
The Gateway to Local Adoption Series

Latest content